ATXN1 Protein Family and CIC Regulate Extracellular Matrix Remodeling and Lung Alveolarization

Developmental Cell

Volumn 21, Issue 4, 2011, Pages 746-757

  Lee, Yoontae ^a   Fryer, John D ^a   Kang, Hyojin ^a   Crespo Barreto, Juan ^a   Bowman, Aaron B ^a   Gao, Yan ^a   Kahle, Juliette J ^a   Hong, Jeong Soo ^a   Kheradmand, Farrah ^a   Orr, Harry T ^b   Finegold, Milton J ^a   Zoghbi, Huda Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Institute of Human Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; GELATINASE B; MATRIX METALLOPROTEINASE; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL REPRESSOR CAPICUA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HYDROCEPHALUS; MOUSE; MOUSE MUTANT; NONHUMAN; OMPHALOCELE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANOGENESIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-ETS; PULMONARY ALVEOLI; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS;

EID: 80054734186     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2011.08.017     Document Type: Article

References (49)

1. Ajuria L., Nieva C., Winkler C., Kuo D., Samper N., Andreu M.J., Helman A., González-Crespo S., Paroush Z., Courey A.J., Jiménez G. Capicua DNA-binding sites are general response elements for RTK signaling in Drosophila. Development 2011, 138:915-924.
2. Antoniou S.A., Antoniou G.A., Granderath F.A., Simopoulos C. The role of matrix metalloproteinases in the pathogenesis of abdominal wall hernias. Eur. J. Clin. Invest. 2009, 39:953-959.
3. Banfi S., Servadio A., Chung M.Y., Kwiatkowski T.J., McCall A.E., Duvick L.A., Shen Y., Roth E.J., Orr H.T., Zoghbi H.Y. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat. Genet. 1994, 7:513-520.
4. Bettegowda C., Agrawal N., Jiao Y., Sausen M., Wood L.D., Hruban R.H., Rodriguez F.J., Cahill D.P., McLendon R., Riggins G., et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 2011, 333:1453-1455.
5. Bowman A.B., Lam Y.C., Jafar-Nejad P., Chen H.-K., Richman R., Samaco R.C., Fryer J.D., Kahle J.J., Orr H.T., Zoghbi H.Y. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes. Nat. Genet. 2007, 39:373-379.
6. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T.C., Qin J., Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
7. Crespo-Barreto J., Fryer J.D., Shaw C.A., Orr H.T., Zoghbi H.Y. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet. 2010, 6:e1001021.
8. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4:3.
9. Díaz-Sanjuán T., García-Ruiz I., Rodríguez-Juan C., Muñoz-Yagüe T., Solís-Muñoz P., Solís-Herruzo J.A. Interferon alpha increases metalloproteinase-13 gene expression through a polyomavirus enhancer activator 3-dependent pathway in hepatic stellate cells. J. Hepatol. 2009, 50:128-139.
10. Dissanayake K., Toth R., Blakey J., Olsson O., Campbell D.G., Prescott A.R., MacKintosh C. ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa. Biochem. J. 2011, 433:515-525.
11. Finlay G.A., Russell K.J., McMahon K.J., D'Arcy E.M., Masterson J.B., FitzGerald M.X., O'Connor C.M. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 1997, 52:502-506.
12. Foronjy R.F., Okada Y., Cole R., D'Armiento J. Progressive adult-onset emphysema in transgenic mice expressing human MMP-1 in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284:L727-L737.
13. Foronjy R., Nkyimbeng T., Wallace A., Thankachen J., Okada Y., Lemaitre V., D'Armiento J. Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L1149-L1157.
14. Greenlee K.J., Werb Z., Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol. Rev. 2007, 87:69-98.
15. Gum R., Lengyel E., Juarez J., Chen J.H., Sato H., Seiki M., Boyd D. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 1996, 271:10672-10680.
16. Hida K., Shindoh M., Yasuda M., Hanzawa M., Funaoka K., Kohgo T., Amemiya A., Totsuka Y., Yoshida K., Fujinaga K. Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities. Am. J. Pathol. 1997, 150:2125-2132.
17. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
18. Jiménez G., Guichet A., Ephrussi A., Casanova J. Relief of gene repression by torso RTK signaling: role of capicua in Drosophila terminal and dorsoventral patterning. Genes Dev. 2000, 14:224-231.
19. Kan Z., Jaiswal B.S., Stinson J., Janakiraman V., Bhatt D., Stern H.M., Yue P., Haverty P.M., Bourgon R., Zheng J., et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010, 466:869-873.
20. Kawamura-Saito M., Yamazaki Y., Kaneko K., Kawaguchi N., Kanda H., Mukai H., Gotoh T., Motoi T., Fukayama M., Aburatani H., et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum. Mol. Genet. 2006, 15:2125-2137.
21. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
22. Kheradmand F., Kiss A., Xu J., Lee S.-H., Kolattukudy P.E., Corry D.B. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 2002, 169:5904-5911.
23. Kurpios N.A., Sabolic N.A., Shepherd T.G., Fidalgo G.M., Hassell J.A. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J. Mammary Gland Biol. Neoplasia 2003, 8:177-190.
24. Lam Y.C., Bowman A.B., Jafar-Nejad P., Lim J., Richman R., Fryer J.D., Hyun E.D., Duvick L.A., Orr H.T., Botas J., Zoghbi H.Y. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 2006, 127:1335-1347.
25. Leco K.J., Waterhouse P., Sanchez O.H., Gowing K.L., Poole A.R., Wakeham A., Mak T.W., Khokha R. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J. Clin. Invest. 2001, 108:817-829.
26. Lim J., Hao T., Shaw C., Patel A.J., Szabó G., Rual J.-F., Fisk C.J., Li N., Smolyar A., Hill D.E., et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006, 125:801-814.
27. Liu Y., Jiang H., Crawford H.C., Hogan B.L.M. Role for ETS domain transcription factors Pea3/Erm in mouse lung development. Dev. Biol. 2003, 261:10-24.
28. Matilla A., Roberson E.D., Banfi S., Morales J., Armstrong D.L., Burright E.N., Orr H.T., Sweatt J.D., Zoghbi H.Y., Matzuk M.M. Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J. Neurosci. 1998, 18:5508-5516.
29. Mizutani A., Wang L., Rajan H., Vig P.J.S., Alaynick W.A., Thaler J.P., Tsai C.-C. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. EMBO J. 2005, 24:3339-3351.
30. Muñoz N.M., Upton M., Rojas A., Washington M.K., Lin L., Chytil A., Sozmen E.G., Madison B.B., Pozzi A., Moon R.T., et al. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res. 2006, 66:9837-9844.
31. Oblander S.A., Zhou Z., Gálvez B.G., Starcher B., Shannon J.M., Durbeej M., Arroyo A.G., Tryggvason K., Apte S.S. Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation. Dev. Biol. 2005, 277:255-269.
32. Orr H.T., Chung M.Y., Banfi S., Kwiatkowski T.J., Servadio A., Beaudet A.L., McCall A.E., Duvick L.A., Ranum L.P., Zoghbi H.Y. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 1993, 4:221-226.
33. Oshima M., Oshima H., Taketo M.M. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 1996, 179:297-302.
34. Qin L., Liao L., Redmond A., Young L., Yuan Y., Chen H., O'Malley B.W., Xu J. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol. Cell. Biol. 2008, 28:5937-5950.
35. Qu P., Du H., Wang X., Yan C. Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition. Cancer Res. 2009, 69:7252-7261.
36. Robbesom A.A., Versteeg E.M.M., Veerkamp J.H., van Krieken J.H.J.M., Bulten H.J., Smits H.T.J., Willems L.N.A., van Herwaarden C.L.A., Dekhuijzen P.N.R., van Kuppevelt T.H. Morphological quantification of emphysema in small human lung specimens: comparison of methods and relation with clinical data. Mod. Pathol. 2003, 16:1-7.
37. Roch F., Jiménez G., Casanova J. EGFR signalling inhibits Capicua-dependent repression during specification of Drosophila wing veins. Development 2002, 129:993-1002.
38. Roy R., Yang J., Moses M.A. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 2009, 27:5287-5297.
39. Shi W., Bellusci S., Warburton D. Lung development and adult lung diseases. Chest 2007, 132:651-656.
40. Siepel A., Bejerano G., Pedersen J.S., Hinrichs A.S., Hou M., Rosenbloom K., Clawson H., Spieth J., Hillier L.W., Richards S., et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005, 15:1034-1050.
41. Sjöblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
42. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. Article3.
43. Suzuki N., Labosky P.A., Furuta Y., Hargett L., Dunn R., Fogo A.B., Takahara K., Peters D.M., Greenspan D.S., Hogan B.L. Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid. Development 1996, 122:3587-3595.
44. Thumkeo D., Shimizu Y., Sakamoto S., Yamada S., Narumiya S. ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. Genes Cells 2005, 10:825-834.
45. Wyss-Coray T., Feng L., Masliah E., Ruppe M.D., Lee H.S., Toggas S.M., Rockenstein E.M., Mucke L. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am. J. Pathol. 1995, 147:53-67.
46. Yan C., Boyd D.D. Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. 2007, 211:19-26.
47. Zechel J., Gohil H., Lust W.D., Cohen A. Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus. J. Neurosci. Res. 2002, 69:662-668.
48. Zhao K., Sun H., Shan Y., Mao B.Y., Zhang H. Cerebrospinal fluid absorption disorder of arachnoid villi in a canine model of hydrocephalus. Neurol. India 2010, 58:371-376.
49. Zoghbi H.Y., Orr H.T. Spinocerebellar ataxia type 1. Semin. Cell Biol. 1995, 6:29-35.